StonvexLoading…
StonvexStonvexStonvexCore line items from BGMS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $747.00K | $43.00K | $420.00K | $0.00 |
Operating Income | $-8.43M | $-12.00M | $-25.45M | $-27.66M |
Net Income | $-3.00M | $-11.21M | $-22.55M | $-21.20M |
EPS (Diluted) | $-6.45 | $-502.46 | $-6419.18 | $-27.24 |
Total Assets | $8.19M | $4.09M | $8.80M | $28.05M |
Total Liabilities | $1.34M | $6.27M | $8.20M | $7.62M |
Cash & Equivalents | $3.50M | $3.14M | $3.38M | $18.34M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-16.12M | $-20.83M |
Shares Outstanding | 5.40M | 36.91K | 4.41K | 628.14K |